These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21130874)

  • 1. Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.
    Watts AB; Peters JI; Talbert RL; O'Donnell KP; Coalson JJ; Williams RO
    Eur J Pharm Biopharm; 2011 Feb; 77(2):207-15. PubMed ID: 21130874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model.
    Watts AB; Cline AM; Saad AR; Johnson SB; Peters JI; Williams RO
    Int J Pharm; 2010 Jan; 384(1-2):46-52. PubMed ID: 19782740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.
    Meçule A; Tinti F; Bachetoni A; Poli L; D'Alessandro M; Alessandri C; Umbro I; Nofroni I; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1017-9. PubMed ID: 21620040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
    McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
    Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
    Deuse T; Blankenberg F; Haddad M; Reichenspurner H; Phillips N; Robbins RC; Schrepfer S
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):403-12. PubMed ID: 19880819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of inhaled tacrolimus in rat lung transplantation.
    Ide N; Nagayasu T; Matsumoto K; Tagawa T; Tanaka K; Taguchi T; Sumida Y; Nakashima M
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):548-53. PubMed ID: 17258598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
    Chan L; Hartmann E; Cibrik D; Cooper M; Shaw LM
    Transplantation; 2010 Jul; 90(1):31-7. PubMed ID: 20517177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
    Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
    Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model.
    Das NA; Peters JI; Simmons JD; Wang Y; O'Donnell KP; DeArmond DT; Coalson JJ; Brooks EG; Johnson SB
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2144-2151.e1. PubMed ID: 28942970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation.
    Imanishi Y; Matsui K; Ishida K; Ito S; Matsuura K; Deguchi T; Itoh Y
    Arzneimittelforschung; 2011; 61(3):191-6. PubMed ID: 21528645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
    Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
    Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inhaled FK 506 on the suppression of acute rejection after lung transplantation: use of a rat orthotopic lung transplantation model.
    Ingu A; Komatsu K; Ichimiya S; Sato N; Hirayama Y; Morikawa M; Abe T
    J Heart Lung Transplant; 2005 May; 24(5):538-43. PubMed ID: 15896750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
    Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
    Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
    Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.